Eastover Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Eastover Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $397,678 - $429,051	-5,875 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $85,367 - $93,275	-1,345 Reduced 18.63%	5,875 $405,000
Q1 2021 Apr 19, 2021	SELL	$60.0 - $68.46 $84,300 - $96,186	-1,405 Reduced 16.29%	7,220 $467,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $19,261 - $21,947	-340 Reduced 3.79%	8,625 $502,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $32,788 - $41,226	-528 Reduced 5.56%	8,965 $566,000
Q1 2020 Apr 20, 2020	BUY	$62.63 - $80.22 $594,546 - $761,528	9,493 New	9,493 $710,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Eastover Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eastover Investment Advisors LLC with notifications on news.